Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2009 Apr;203(2):610-4.
doi: 10.1016/j.atherosclerosis.2008.07.031. Epub 2008 Aug 5.

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)

Affiliations
Clinical Trial

Association between IL-6 and the extent of coronary atherosclerosis in the veterans affairs diabetes trial (VADT)

Aramesh Saremi et al. Atherosclerosis. 2009 Apr.

Abstract

Aims: The aim of the present study was to investigate the association of high-sensitivity C-reactive protein (CRP), interleukin-6 (IL-6) and lipoprotein-associated phospholipase A2 (Lp-PLA2) with the extent of calcified coronary atherosclerosis in patients with type 2 diabetes mellitus (T2DM).

Materials and results: This is a cross-sectional study of 306 subjects aged 40years or older who were enrolled into the veterans affairs diabetes trial (VADT). Calcified coronary atherosclerosis was assessed using electron beam computed tomography scored by the Agatston method. Clinical parameters, traditional cardiovascular risk factors and plasma levels of CRP, IL-6 and Lp-PLA2 were measured at the time of the scan. Coronary artery calcium (CAC) scores increased stepwise across increasing categories of IL-6, but did not change across increasing categories of CRP and Lp-PLA2. After adjustment for traditional cardiovascular risk factors, IL-6 was significantly associated with CAC scores (p=0.05). The association between IL-6 and CAC was largely in those with lower (below the median) abdominal artery calcium (AAC) levels (p=0.04).

Conclusions: Despite a generally higher level of systemic inflammation in T2DM, the inflammatory marker IL-6 remained significantly associated with CAC score, particularly in those subjects with lower AAC scores.

PubMed Disclaimer

Conflict of interest statement

Duality of interest The authors attest that no conflict of interest or duality exists related to this work.

Figures

Figure 1
Figure 1. Coronary artery calcium levels by tertiles of IL-6
Geometric means and 95% CI are shown for CAC levels by IL-6 tertiles for subjects with all data available (n =273). P-value= 0.11 from Kruskal-Wallis test.
Figure 2
Figure 2. Coronary artery calcium levels by tertiles of IL-6 according to AAC levels
Geometric means and 95% CI are shown for CAC levels by tertiles of IL-6 as defined for the entire group (see Fig. 1). Panel A: CAC values by tertiles of IL-6 in those with lower AAC (< median value of 1217). Numbers of subjects in categories I, II and III were 53, 39 and 44, respectively. P-value= 0.02 from Kruskal-Wallis test. Panel B: CAC values by tertiles of IL-6 in those with higher AAC (≥ median). Numbers of subjects in categories I, II and III were 38, 51 and 48, respectively. P-value= 0.76 from Kruskal-Wallis test.

Similar articles

Cited by

References

    1. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836–843. - PubMed
    1. Tuomisto K, Jousilahti P, Sundvall J, Pajunen P, Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost. 2006;95:511–518. - PubMed
    1. Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study 1. Circulation. 2004;109:837–842. - PubMed
    1. Sabatine MS, Morrow DA, Cannon CP, et al. Relationship between baseline white blood cell count and degree of coronary artery disease and mortality in patients with acute coronary syndromes: a TACTICS-TIMI 18 (Treat Angina with Aggrastat and determine Cost of Therapy with an Invasive or Conservative Strategy- Thrombolysis in Myocardial Infarction 18 trial)substudy. J Am Coll Cardiol. 2002;40:1761–1768. - PubMed
    1. Stewart RA, White HD, Kirby AC, et al. White blood cell count predicts reduction in coronary heart disease mortality with pravastatin. Circulation. 2005;111:1756–1762. - PubMed

Publication types

Substances